期刊文献+

Intramuscular Diffusion Status of Risperidone and Aripiprazole Long Acting Injectable (LAI) by Ultrasonography

Intramuscular Diffusion Status of Risperidone and Aripiprazole Long Acting Injectable (LAI) by Ultrasonography
下载PDF
导出
摘要 The aim of this study was to consider the characteristics of intramuscular diffusion status of risperidone and aripiprazole long acting injectable (LAI) by ultrasonography. Subjects were 40 adult subjects diagnosed with schizophrenia and treated with LAI [32 patients were risperidone LAI (RLAI) and 8 patients were aripiprazole LAI (ALAI)]. However, in this paper, only three cases (one RLAI case and 2 ALAI cases) were selected to illustrate the diffusion effects of both LAI. Dorsogluteal intramuscular (IM) injection sites were measured at prone position using the “double cross” method. Before LAI injection, the distance from the epidermis to the under-fascia (DEUF), and distance from the epidermis to the iliac bone (DEI) at the IM injection site were assessed by using ultrasonography: 1) the injection needle was inserted to the gluteus medius, and 2) observed the diffusion status within the muscle injected RLAI and ALAI were confirmed using the B-mode ultrasonography. Both RLAI and ALAI were depicted as high echogenicity with acoustic shadowing. It was considered that the diffusion states of LAIs by ultrasonography were important time course evaluations providing objective evidence. The aim of this study was to consider the characteristics of intramuscular diffusion status of risperidone and aripiprazole long acting injectable (LAI) by ultrasonography. Subjects were 40 adult subjects diagnosed with schizophrenia and treated with LAI [32 patients were risperidone LAI (RLAI) and 8 patients were aripiprazole LAI (ALAI)]. However, in this paper, only three cases (one RLAI case and 2 ALAI cases) were selected to illustrate the diffusion effects of both LAI. Dorsogluteal intramuscular (IM) injection sites were measured at prone position using the “double cross” method. Before LAI injection, the distance from the epidermis to the under-fascia (DEUF), and distance from the epidermis to the iliac bone (DEI) at the IM injection site were assessed by using ultrasonography: 1) the injection needle was inserted to the gluteus medius, and 2) observed the diffusion status within the muscle injected RLAI and ALAI were confirmed using the B-mode ultrasonography. Both RLAI and ALAI were depicted as high echogenicity with acoustic shadowing. It was considered that the diffusion states of LAIs by ultrasonography were important time course evaluations providing objective evidence.
作者 Yuko Yasuhara Tetsuya Tanioka Kensaku Takase Kazushi Motoki Chie Watari Koichi Makiguchi Asumi Atsuta Rozzano C. Locsin Yuko Yasuhara;Tetsuya Tanioka;Kensaku Takase;Kazushi Motoki;Chie Watari;Koichi Makiguchi;Asumi Atsuta;Rozzano C. Locsin(Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan;Tokushima Prefectural Central Hospital, Tokushima, Japan;Tokushima Prefectural Kaifu Hospital, Tokushima, Japan;Fujishiro Kensei Hospital, Hirosaki, Japan;Graduate School of Health Sciences, Tokushima University, Tokushima, Japan)
出处 《Open Journal of Psychiatry》 2016年第2期165-172,共8页 精神病学期刊(英文)
关键词 Diffusion Status RISPERIDONE ARIPIPRAZOLE Long Acting Injectable (LAI) ULTRASONOGRAPHY Diffusion Status Risperidone Aripiprazole Long Acting Injectable (LAI) Ultrasonography
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部